Point72 Asset Management »

Bridgebio Oncology Therapeut shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Bridgebio Oncology Therapeut (BBOT) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Bridgebio Oncology Therapeut

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Oncology Therapeut held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Oncology Therapeut by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $295k 24k 12.52

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Amazon (AMZN)
Broadcom (AVGO)
Arista Networks Com Shs (ANET)
Microsoft Corporation (MSFT)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Asml Holding N V N Y Registry Shs (ASML)
Spotify Technology S A SHS (SPOT)
Sea Sponsord Ads (SE)
Biogen Idec (BIIB)
Equinix (EQIX)
Coherent Corp (COHR)

View all positions for Point72 Asset Management

Top funds holding Bridgebio Oncology Therapeut

Cormorant Asset Management
Deerfield Management Company
Omega Fund Management
Wellington Management Company
EcoR1 Capital
Alphabet
Enavate Sciences GP
Citadel Advisors
Paradigm Biocapital Advisors
BlackRock
Novo A/S
Adage Capital Partners GP
Laurion Capital Management
Eventide Asset Management
Octagon Capital Advisors

View all funds holding Bridgebio Oncology Therapeut